Royce & Associates LP Takes Position in Vitamin Shoppe Inc (NYSE:VSI)

Royce & Associates LP bought a new position in Vitamin Shoppe Inc (NYSE:VSI) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 47,886 shares of the specialty retailer’s stock, valued at approximately $337,000. Royce & Associates LP owned 0.20% of Vitamin Shoppe at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Oregon Public Employees Retirement Fund bought a new stake in Vitamin Shoppe during the fourth quarter worth about $28,000. Investors Research Corp bought a new stake in shares of Vitamin Shoppe during the first quarter valued at approximately $34,000. Optimum Investment Advisors bought a new stake in shares of Vitamin Shoppe during the first quarter valued at approximately $35,000. Quantamental Technologies LLC bought a new stake in shares of Vitamin Shoppe during the fourth quarter valued at approximately $39,000. Finally, Texas Permanent School Fund bought a new stake in shares of Vitamin Shoppe during the fourth quarter valued at approximately $48,000. Hedge funds and other institutional investors own 88.97% of the company’s stock.

VSI stock traded down $0.17 during midday trading on Monday, reaching $3.77. The company’s stock had a trading volume of 305,800 shares, compared to its average volume of 540,475. The stock’s 50-day moving average price is $4.04. The company has a debt-to-equity ratio of 2.36, a quick ratio of 0.16 and a current ratio of 1.14. The stock has a market capitalization of $94.54 million, a PE ratio of 14.50 and a beta of 1.66. Vitamin Shoppe Inc has a 52 week low of $3.32 and a 52 week high of $13.95.

Vitamin Shoppe (NYSE:VSI) last posted its earnings results on Wednesday, May 8th. The specialty retailer reported $0.21 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.24 by ($0.03). The firm had revenue of $283.33 million during the quarter. Vitamin Shoppe had a return on equity of 4.64% and a net margin of 0.33%. Analysts predict that Vitamin Shoppe Inc will post 0.54 earnings per share for the current year.

VSI has been the topic of several research analyst reports. Zacks Investment Research cut shares of Vitamin Shoppe from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, May 1st. ValuEngine cut shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Friday, March 15th. Finally, Jefferies Financial Group began coverage on shares of Vitamin Shoppe in a research note on Monday, June 17th. They issued a “hold” rating and a $4.00 price objective on the stock. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $7.92.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.

Featured Article: How is a buy-side analyst different from a sell-side analyst?

Institutional Ownership by Quarter for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.